SURG vs STXS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

SURG

33.5
AI Score
VS
STXS Wins

STXS

42.2
AI Score

Investment Advisor Scores

SURG

34score
Recommendation
SELL

STXS

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SURG STXS Winner
Revenue 32.19M 13.96M SURG
Net Income -10.76M -10.33M STXS
Net Margin -33.4% -74.0% SURG
Operating Income -7.75M -10.55M SURG
ROE 52.0% -84.4% SURG
ROA -116.5% -18.6% STXS
Total Assets 9.24M 55.58M STXS
Cash 1.95M 10.49M STXS
Current Ratio 0.19 1.42 STXS

Relative Price Performance (Last 90 Days)

SURG 1M: +18.0% · 3M: -38.9% STXS 1M: -18.0% · 3M: -37.0%

Current Technical Phase

SURG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.2 · Price: $0.15

STXS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.9%), weak momentum, RSI 38

RSI (14): 37.8 · Price: $0.87

Fundamentals Snapshot

Metric SURG STXS
Market Cap — —
Forward P/E 15.8 -6.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.4% -0.1%
Gross Margin -0.2% 0.6%
Operating Margin 0.2% -0.6%
EPS -1.50 -0.24
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, STXS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.